In this episode of Disruptors x CDL: The Innovation Era, John Stackhouse and Sonia Sennik explore the future of Canada’s life sciences sector. With insights from Anne Woods (RBCx), Sue Paish (DIGITAL), and Dr. Christine Allen (Intrepid Labs and University of Toronto), they discuss how AI and emerging technologies are revolutionizing drug discovery and healthcare. Learn how Canada can build on its innovation strengths to lead globally in life-saving treatments as we move into the 2030s.
In this episode of Disruptors x CDL: The Innovation Era, hosts John Stackhouse and Sonia Sennik dive into the rapidly evolving world of life sciences, exploring how Canada can leverage its strengths to lead in global drug discovery and healthcare innovation.
The pandemic accelerated scientific breakthroughs, such as AI-assisted vaccine development, but what will it take for Canada to continue leading into the 2030s? With special guests Anne Woods (Managing Director, Life Sciences, RBCx), Sue Paish (CEO, Digital), and Dr. Christine Allen (CEO, Intrepid Labs), this episode delves into how AI, data, and interdisciplinary collaboration are driving new treatments and medical advancements.
From Canada’s storied history in medical innovation to today’s challenges in scaling life sciences companies, the conversation explores the need for a cohesive strategy, greater investment in early-stage ventures, and an openness to data-driven healthcare solutions.
Listen now to hear expert insights on the future of life sciences, Canada’s unique opportunities, and how AI can reshape the way we discover and deliver life-saving treatments.